"There's a commitment that patients make to the clinical trials ... Here, you've broken a commitment to those individuals,"
"This is the kind of science we think of as being sort of the highest quality science, in terms of the rigor of the evidence that's generated,"
"We want to see more of that kind of research - and not less of it."
"What they also fail to mention is that these terminations likely happened because this research prioritized ideological agendas over scientific rigor and meaningful outcomes for the American people,"
The National Institutes of Health cut about $3.8 billion in grant funding to U.S. institutions earlier this year. NIH terminated grants for 383 clinical trials between Feb. 28 and Aug. 15 out of 11,008 funded during that period. More than 14% of infectious disease trials had funding pulled, about 6% of respiratory illness trials, and 5% of cardiovascular trials. The cuts raise concerns about avoidable waste, compromised data quality, and ethical obligations to patients who enrolled expecting completed studies. It remains unclear whether or how the funding challenges impacted trial outcomes. HHS rejected claims of misleading grant management and said terminations reflected a refocus toward high-impact, high-urgency science and concerns that some research prioritized ideological agendas over scientific rigor.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]